Clinical Trials Browser

Unknown × INDUSTRY × orelabrutinib × Clear all

NCT05234684 2024-02-07

BELIEVE-01

Phase 3 Unknown

Lymphoma, Large B-Cell, Diffuse

NCT05978739 2023-10-25

Evaluating Different Doses of Orelabrutinib in MCL

Phase 2 Unknown

Lymphoma, Mantle-Cell